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ABSTRACT 46 
Background: The increasing global trends in obesity and its associated burden of disease 47 
indicate a need to identify modifiable determinants of obesity. 48 
Methods: A total of 182 nutrition and lifestyles factors were investigated in relation to 49 
abdominal obesity among 7,403 male and 8,328 female participants of the Third U.S. 50 
National Health and Examination Survey (NHANES III). We used the first phase (1988-51 
1991) of the NHANES III to identify factors with a false discovery rate (FDR) of <5%. Of 52 
these, we tentatively replicated our findings in the second phase (1992-1994) of the survey. 53 
Principal component analysis was performed to identify unobserved factors underlying the 54 
association between validated factors and abdominal obesity, defined as waist circumference 55 
>88 cm for women and >102 cm for men.  56 
Results: We found 5 tentatively replicated factors showing significant associations with 57 
abdominal obesity in men: serum α-carotene, -carotene, serum -cryptoxanthin, serum 58 
vitamin D, and vigorous physical activity. In women, 7 factors were identified: serum α-59 
carotene, -carotene, serum -cryptoxanthin, serum vitamin C, serum vitamin D, vigorous 60 
physical activity, and aspartame intake. In contrast to the other factors which showed inverse 61 
associations with abdominal obesity, aspartame intake displayed a positive relationship with 62 
this outcome (OR: 1.18, 95% CI: 1.10-1.26 for each log increase in aspartame intake in 63 
women). Principal component analysis suggested three principal components underlying such 64 
associations, each comprising: 1) serum antioxidants; 2) serum vitamin D and vigorous 65 
physical activity; and 3) aspartame intake. All three principal components also displayed 66 
significant associations with abdominal obesity. 67 
Conclusion: Our observational investigation that systematically investigates multiple 68 
modifiable factors simultaneously has enabled the creation of data-driven hypotheses 69 
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regarding the possible role of determinants of abdominal obesity and has identified potential 70 
avenues for mechanistic investigations to clarify suitable targets of intervention. 71 
Introduction 72 
The obesity pandemic remains a challenging health problem worldwide [1], with 73 
approximately 2.1 billion individuals estimated to be overweight or obese in 2013. Although 74 
some countries have shown indications of rate stabilisation during the past decade, the 75 
prevalence of obesity continues to increase in both developed and developing regions [1–3]. 76 
High body mass index (BMI), a widely accepted indicator of obesity, is a well-known risk 77 
factor for diseases with serious implications including cardiovascular disease and several 78 
cancers [4,5], and accounted for over 33 million disability-adjusted life years (DALYs) lost 79 
in 2000 [6]. Moreover, obesity-related diseases confer a large economic burden, with an 80 
estimated rise in total medical costs of $48–66 billion/year in the U.S. and £1.9–2 billion/year 81 
in the UK by 2030 [7]. Nevertheless, outcomes of public health strategies aimed at reducing 82 
obesity rates are unsatisfactory. Although interventions based on reduction in energy intake 83 
lead to weight loss, the lengthy period required for an obese individual to reach their normal 84 
weight implies limited efficiency [8], which indicates that policies should be directed towards 85 
obesity prevention rather than its reversal. 86 
 87 
Identification of suitable targets of obesity prevention requires an understanding of at least 88 
two key concepts: 1) clinically relevant definition of obesity and 2) factors involved in 89 
mechanisms underlying obesity. Although obesity is conventionally defined by high BMI, the 90 
Third Report of Adult Treatment Panel (ATP III) of the National Cholesterol Education 91 
Program refers to waist circumference as the recommended measurement since abdominal 92 
obesity is closely related to metabolic disorders such as abnormal lipid profile, glucose 93 
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tolerance, and blood pressure [9]. Nevertheless, heterogeneity in other metabolic features has 94 
been reported within the same obesity categories [10], which underlines the importance of 95 
taking into account variation in metabolic indicators in assessing determinants of obesity. 96 
 97 
Although around 40% of obesity cases are considered heritable [11,12], environmental 98 
factors such as energy intake and physical activity remain the major driving forces underlying 99 
obesity [13]. Additionally, environmental factors may indirectly contribute to obesity through 100 
interaction with susceptibility genes [14]. Many studies have documented correlations 101 
between these factors and obesity, but most of them focused on individual associations 102 
without their co-existence, which is in contrast with a real life situation. Recently, Patel and 103 
colleagues introduced an environment-wide association study approach derived from 104 
methods used in genome-wide association studies (GWAS) to investigate the association of 105 
multiple nutrition and environmental factors with clinical phenotypes including blood 106 
pressure, diabetes, and mortality [15–17]. Here, we utilised this approach to comprehensively 107 
assess nutrition and lifestyle factors in relation to abdominal obesity in the Third U.S. 108 
Nutrition Health and Examination Survey (NHANES III). Additionally, we took into account 109 
other metabolic disorders and unobserved underlying factors while assessing abdominal 110 
obesity. 111 
Methods 112 
Study population 113 
The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional 114 
health survey conducted by the National Center for Health Statistics (NCHS) in 115 
representative samples of the non-institutionalized U.S. population [18]. Participants were 116 
selected through a multistage stratified, clustered probability sampling. The survey included 117 
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an interview conducted at home and an extensive physical examination with a blood sample 118 
taken in a mobile examination center (MEC). Institutional Review Board (IRB) approval was 119 
obtained for the NHANES and documented consent was obtained from participants. The 120 
present study was based on data from the Third NHANES (NHANES III) which was 121 
performed in two phases: 1988-1991 and 1991-1994, each of which provides independent 122 
unbiased national estimates of health and nutrition characteristics. From this population, we 123 
selected a total of 15,721 participants (7,403 men and 8,328 women) aged 20 and older with 124 
measurements of waist circumference. The first phase of NHANES III (N = 7,743) was used 125 
as a discovery set and findings from this dataset were replicated in the second phase of 126 
NHANES III (N = 7,988). 127 
Obesity assessment 128 
Abdominal obesity referred to waist circumference (WC) of >88 cm in women and >92 cm in 129 
men as defined by the experts in the Adult Treatment Panel (ATP) under the National 130 
Cholesterol Education Program (NCEP) [9]. All body measurements were performed using 131 
standardized methods and equipment [18]. WC was measured at the high point of the iliac 132 
crest at minimal respiration using a steel measuring tape to the nearest 1 mm [18]. Waist-to-133 
hip ratio was calculated from WC and hip circumference. Body mass index (BMI) was 134 
calculated from measured weight and height. Weight was measured with an electronic weight 135 
scale in pounds and automatically converted to kilograms. Participants only wore underwear, 136 
disposable paper gowns and foam rubber slippers. Standing height was measured with a fixed 137 
stadiometer to the nearest 1 mm.  138 
Assessment of exposures and covariates 139 
A total of 182 nutrition and lifestyle factors in NHANES III were assessed (Table S1, 140 
Supplementary Data). Data collected ranged from information obtained through the 141 
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interview, such as smoking history, as well as physical and laboratory examination, e.g. 142 
serum vitamin C concentrations. Examples of markers and categories are presented in Table 143 
1. Excluding reproductive-related factors such as external hormone use, 176 factors were 144 
equally assessed in both men and women. These factors were assessed either as continuous or 145 
categorical variables. The majority of continuous variables had a right-skewed distribution. 146 
We transformed these variables into standardised z-scores by subtracting the mean and 147 
dividing by the standard deviation (SD) of the population. For categorical variables, we 148 
consistently defined one value as the referent category or the “negative” result, e.g. “never 149 
smoker” as the reference for “current smoker”. Vigorous physical activity (yes, no) was 150 
defined as participating three or more times per week in leisure-time physical activities with 151 
metabolic equivalent (MET) ≥6 for those aged 60 and older, and MET ≥7 for those younger 152 
than 60 [19]. Secondary exposure to smoking among never smokers (never smoked ≥100 153 
cigarettes) was defined as exposure to smoke at home (≥1 person smoke at home) or at work 154 
(≥1 hours smoke exposure at work). All exposure variables were assessed with standard 155 
procedures as detailed in the NHANES III documentation [18,20].  156 
 157 
The following variables have been suggested to strongly affect environmental factors and 158 
obesity and were therefore considered as confounders in our study: age, sex, race/ethnicity, 159 
education and socioeconomic status (SES). Race/ethnicity was categorised into Non-Hispanic 160 
white, Non-Hispanic black, Mexican-American, and other. We classified educational 161 
attainment as less than high school, high school equivalent, and higher than high school. SES 162 
was estimated with poverty-to-income ratio (PIR), a ratio of total family income to the 163 
official poverty threshold at the family level. A PIR <1 indicated that income was less than 164 
the level of poverty. We categorised PIR into <1, 1-<2, 2-<3, and ≥3, indicating lowest to 165 
highest SES as previously described [21]. 166 
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 167 
The ATP-III definition of metabolic syndrome apart from waist circumference was used to 168 
define presence of other metabolic disorders [9]. Hypertension was defined by blood pressure 169 
of ≥130/≥85 mmHg or any use of antihypertensive drugs. Diabetes was defined as fasting 170 
glucose ≥110 mg/dL or any use of insulin or glucose-lowering drugs. Any HDL-cholesterol 171 
levels <40 mg/dL for men or <50 mg/dL for women were considered as low. 172 
Triglyceridaemia was defined as any levels of triglycerides ≥150 mg/dL. Blood pressure was 173 
measured with mercury manometer and the average of the second and third blood pressure 174 
measurements was taken. Fasting plasma glucose levels were measured by using a modified 175 
hexokinase enzymatic method (Roche Diagnostic Systems, Inc., Montclair, NJ). Blood lipids 176 
were enzymatically measured using the Hitachi 704 Analyzer (Boehringer Mannheim 177 
Diagnostics, Indianapolis, IN) [18].  178 
Statistical analysis 179 
Sampling weights specific to each phase were included in all analyses. Fig 1 summarises the 180 
analytical steps in this study which were similar to previously published nutrient- and 181 
environment-wide studies [15,16,22,23]. WC was used as an outcome instead of BMI, and 182 
was assessed as a dichotomous instead of a continuous outcome given that this definition of 183 
abdominal obesity has been widely accepted to be clinically relevant to risk of diabetes and 184 
cardiovascular disease [24]. We selected factors corresponding to categories of 185 
environmental exposures used in a previous EWAS study as summarised in Table 1 [16].  186 
First, each of the 182 nutrition and lifestyle factors was assessed in relation to abdominal 187 
obesity in the discovery set, phase I of the NHANES III. Survey-weighted logistic regression 188 
was used to examine the association of continuous and dichotomous nutrition and lifestyle 189 
factors in men and women separately. All models were linearly adjusted for age, 190 
race/ethnicity, education and PIR by adding each term into the regression model.  191 
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 192 
Next, we estimated the false discovery rate (FDR) among findings in the discovery set. FDR 193 
is the expected proportion of false discoveries, among all significant findings at a given 194 
significance level [25]. Using a significance level α of 0.05, we estimated FDR using the 195 
Benjamini-Hochberg step down method [26] to select factors with statistically significant 196 
association with obesity status and FDR<5% in the discovery set. A sensitivity analysis was 197 
performed by selecting all factors with FDR<1%. Because physical activity and smoking 198 
status classifications were derived from other variables, we performed a sensitivity analysis 199 
including the four categories of physical activity (vigorous, moderate, light physical activity, 200 
and sedentary) [19] instead of using it dichotomously. Similarly, for smoking status we 201 
repeated our analyses by only including the main smoking categorisation (current, former and 202 
never smokers) [27] and continuous levels of serum cotinine, the primary metabolite of 203 
nicotine [28], as indicators of smoking exposures. 204 
 205 
Replicated analysis of assessed nutrition and lifestyle factors was subsequently performed by 206 
re-running similar logistic regression models in the second dataset, namely phase II of 207 
NHANES III (Fig 1). Only nutrition or lifestyle factors with both FDR <5% in the first 208 
dataset and p value <0.05 in the replication set were considered valid. Furthermore, analysis 209 
for replicated factors in the overall study population was repeated in additional multivariable 210 
models adjusting for other metabolic disorders (i.e., hypertension, diabetes, low HDL, and 211 
hypertriglyceridaemia) and models incorporating all replicated factors. To account for 212 
potential effects of body type differences, a sensitivity analysis was performed by a further 213 
adjustment for BMI or waist-to-hip ratio as a continuous variable. 214 
 215 
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Finally, our secondary aim was to understand any underlying factors associated with 216 
abdominal obesity based on inter-correlation among tentatively replicated nutrition and 217 
lifestyle factors in the overall study population. For this purpose, we performed a principal 218 
component analysis with an orthogonal varimax rotation procedure. An eigenvalue of >1 was 219 
used to define the number of principal components to be extracted from our data [29]. 220 
Proportion of variance in abdominal obesity explained by each principal component was 221 
estimated, and 95% confidence intervals of this estimation were obtained using 1000 222 
bootstrap resampling [30]. We further estimated the value of principal components identified 223 
and assessed them in relation to abdominal obesity using similar multivariable approach. 224 
McFadden R2 values were computed to estimate variance explained by the model, and the 225 
variance explained only by replicated nutrition and lifestyle factors or principal components. 226 
 227 
The NHANES III datasets were prepared with Statistical Analysis Software (SAS) release 9.3 228 
(SAS Institute, Cary, NC). All analyses were performed with R version 3.1.2 (R Foundation 229 
for Statistical Computing). The survey package was used to account for sampling weights and 230 
the psych package was used to perform principal component analysis. 231 
Results 232 
Characteristics of study participants are shown in Table 2, whereas means, standard 233 
deviations and frequencies of investigated nutrition and lifestyle factors are available in Table 234 
S1 (Supplementary Information).Using the ATP III definition for abdominal obesity, 55.6% 235 
of women and 28.8% of men were abdominally obese. Prevalence of other metabolic 236 
disorders was higher in both obese men and women compared to the non-obese counterparts.  237 
 238 
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We performed a systematic screening of the relationships of the 182 nutrition and lifestyle 239 
factors with abdominal obesity in men and women separately. A total of 30 factors with 240 
FDR<5% in men and 36 factors in women in the discovery set were examined for 241 
significance (P<0.05) in the replication set. In men, this resulted in 5 tentatively replicated 242 
factors showing significant inverse associations for serum α-carotene, -carotene, serum -243 
cryptoxanthin, serum vitamin D, and vigorous physical activity with abdominal obesity 244 
(Table 3). A total of 7 factors were replicated in women: serum vitamin C, serum α-carotene, 245 
-carotene, serum -cryptoxanthin, serum vitamin D, and vigorous physical activity were 246 
inversely correlated with abdominal obesity, whereas aspartame intake was positively 247 
associated with abdominal obesity. Replicated findings did not alter when we performed a 248 
sensitivity analysis including only factors with FDR<1% in the discovery survey or when we 249 
used the alternative categorisation of physical activity and smoking status (results not 250 
shown). Fig 2 depicts the distribution of P-values for each investigated factor and effect sizes 251 
(“Manhattan plot”). As seen in Fig 2, stronger associations between common factors and 252 
abdominal obesity were observed in women compared to men. Detailed results on 253 
associations between all factors and abdominal obesity are presented in the Supplementary 254 
Information (Table S2 and S3). 255 
 256 
Correlation between replicated factors is displayed as a heatmap in Fig S1 (Supplementary 257 
Information). To assess any structure underlying replicated nutrition and lifestyle factors, we 258 
performed a principal component factor analysis to identify common underlying factors. In 259 
men, two principal components (PC) were identified. The first PC mainly consisted of serum 260 
antioxidants (antioxidant PC). The second PC comprised serum vitamin D and vigorous 261 
physical activity (exercise-related PC). In addition to these two factors, a third factor (food 262 
additive PC) was identified in women, which only included aspartame intake. The total 263 
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variance of replicated variables explained by these principal components in men was 36% 264 
(95% CI: 34-36%) by antioxidant PC and 22% (21-22%) by exercise-related PC. In women, 265 
29% (95% CI: 29-31%) of total variance was explained by antioxidant PC, 16% (15-16%) by 266 
exercise-related PC, and 15% (14-15%) by food additive PC). 267 
 268 
For the final analysis, we obtained estimates for replicated nutrition and lifestyle factors in 269 
relation to abdominal obesity in the overall survey (phase I and phase II) for men and women 270 
(Table 4). In addition to these factors, we calculated estimates for antioxidant PC and 271 
exercise-related PC from the principal component analysis. We found that these two principal 272 
components were inversely associated with abdominal obesity in both sexes (Table 4). In a 273 
sensitivity analysis where we adjusted for BMI, only antioxidant PC was consistently 274 
associated with abdominal obesity in both men and women (Table S4). Associations remain 275 
significant for both principal components when models were adjusted for waist-to-hip ratio 276 
(Table S4). 277 
 278 
When we adjusted for other metabolic disorders as denoted by presence of one or more 279 
components of metabolic syndrome apart from obesity, the results were not altered, and all 280 
replicated factors remained significantly associated to abdominal obesity in men and women 281 
(Table 4). In a multivariable model incorporating all replicated factors, a lack of statistically 282 
significant association with abdominal obesity was observed for serum α-carotene in men and 283 
women, and for -cryptoxanthin in women. Other factors and all principal components 284 
identified remained significantly associated with abdominal obesity. The total variance 285 
explained by the multivariable model including replicated nutrition and lifestyle factors was 286 
11% and 17% for men and women, respectively. The total variance explained by replicated 287 
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factors was 2% and 6% in men and women, respectively. Similar contribution to variance 288 
was found for principal components in the multivariable models 289 
Discussion 290 
In a systematic screening of 182 nutrition and lifestyle factors, 5 factors in men and 7 factors 291 
in women were found to have statistically significant associations with abdominal obesity 292 
after applying the EWAS methodology among a representative sample of the U.S. 293 
population. Based on inter-correlation between these factors, three underlying principal 294 
components were identified. Lower odds of being abdominally obese were seen with higher 295 
quantities of factors representing serum antioxidants and exercise in both men and women, 296 
whereas a positive association was observed for aspartame intake in women, but not men.  297 
 298 
Circulating levels of common antioxidants including vitamin A metabolites and vitamin C 299 
have been reported to be inversely associated with general and abdominal obesity [31–35]. 300 
Recently, using repeated measurements, longitudinal associations between levels of these 301 
antioxidants and adiposity indicators were observed in postmenopausal women, indicating 302 
lower serum -carotene and higher γ-tocopherol  to be associated with higher WC [36]. 303 
However, results from clinical studies have failed to demonstrate benefit of antioxidant 304 
supplementation in prevention of obesity-related diseases such as cardiovascular disease [37] 305 
and breast cancer [38], although confounding by fruit and vegetable consumption may be 306 
implicated. Interestingly, a meta-analysis assessing a total of 78 randomised trials showed 307 
increased mortality with supplementation of -carotene or vitamin E, and with higher doses 308 
of vitamin A [39]. Our findings support inverse associations between serum antioxidants and 309 
abdominal obesity which was robust against variation in BMI and waist-to-hip ratio. The 310 
contrasting positive association between vitamin A levels and abdominal obesity, albeit not 311 
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seen in the replication set, may underline the discrepancy between absorbed pro-vitamin A 312 
and the tightly regulated levels of vitamin A [40,41]. In line with this, different associations 313 
between carotenoids and vitamin A levels with respect to other health outcomes such as 314 
mortality have also been noted [42]. Our findings also showed disagreement between dietary 315 
intake and serum levels of antioxidants in relation to obesity. Nevertheless, it is possible that 316 
this discrepancy and the lack of associations for dietary antioxidants that we observed was 317 
due to a lack of precision from measurement error and within-individual variation because 318 
information was obtained by a single 24-hour dietary recall. Alternatively, such discrepancy 319 
may also indicate the implication of physiological regulators of antioxidant metabolism rather 320 
than antioxidant intake on obesity and relevant health outcomes. In support of this, 321 
experimental evidence indicated that circulating carotenoids reduce adiposity through 322 
regulation of adipocyte thermogenesis [43]. These findings may indicate an interplay between 323 
antioxidant metabolism and physiological regulation of adiposity warranting further 324 
investigations. 325 
 326 
The role of physical activity in management of obesity has been well-established [44], as well 327 
as their opposing effects on health outcomes such as cardiovascular death [45]. Similarly, 328 
decreased levels of serum vitamin D among individuals with general and abdominal obesity 329 
have been reported [46–48] but the directionality of this association is unclear. Findings from 330 
a meta-analysis of vitamin D supplementation [49] and a Mendelian randomisation study [50] 331 
suggested that levels of vitamin D decrease secondary to increasing adiposity. Our study 332 
corroborates the inverse relationship between physical activity or serum vitamin D and 333 
abdominal obesity in both men and women. Additionally, from the principal component 334 
analysis, we observed a high correlation between physical activity and serum vitamin D. 335 
Although higher levels of physical activity have been linked to increasing levels of vitamin D 336 
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[51,52], their mechanistic association is unclear. Adding to the current evidence, we 337 
identified from the principal component analysis that an unobserved PC, which we denoted as 338 
‘exercise-related’, drove the associations of physical activity and serum vitamin D with 339 
abdominal obesity. One possible explanation is that levels of vitamin D may be a proxy for a 340 
healthier lifestyle which involves outdoor activities. However, it was suggested that sun 341 
exposure and time spent outdoor do not explain the majority of variation in vitamin D levels 342 
[53]. On the other hand, the notion that obesity is followed by decreasing vitamin D levels 343 
[49,50] may indicate a physical activity-obesity-vitamin D regulation axis. Mechanistic 344 
investigations are needed to confirm these plausible pathways.   345 
 346 
Aspartame is a methyl ester of a dipeptide and widely used as a synthetic non-nutritive 347 
sweetener (NNS) [54]. There is evidence that NNSs may interfere glucose and insulin 348 
response by disrupting learned physiological response [55,56]. However, a position statement 349 
by the Academy of Nutrition and Dietetics concluded that aspartame consumption was not 350 
associated with adverse health effects in humans (Grade I evidence) [57].  In the context of 351 
obesity, weight loss and maintenance among obese women have been reported following diet 352 
regimens incorporating aspartame-sweetened food and beverages, which are often part of 353 
diet-related products such as diet soda, compared to those without [58]. Nevertheless, there is 354 
a lack of evidence apart from clinical trials including individuals on weight management 355 
programmes. We found that higher aspartame intake correlated to more prevalent abdominal 356 
obesity in obese women. Although any obesogenic effect of aspartame intake has not been 357 
well-documented, our findings are in line with previous studies suggesting higher risks of 358 
subsequent general and abdominal obesity following use of artificially-sweetened beverages 359 
[59–61]. On the other hand, the positive association observed between aspartame intake and 360 
abdominal obesity in women may also signify certain behavioural patterns secondary to 361 
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obesity, such as efforts to moderate energy intake [56] and a ‘licensing effect’, since artificial 362 
sweeteners are often a part of diets based on calorie restriction. The latter refers to 363 
disinhibition or ‘licensing’ of unhealthy behaviours following commitment to a self-364 
perceived healthy behaviour [62,63], a phenomenon increasingly recognised in marketing 365 
research and experimental human studies. Further studies are needed to rule out such reverse 366 
causality, which is important in clarifying the role of aspartame in obesity and obesity-related 367 
outcomes. 368 
 369 
One of the strengths of this study is its generalisability following the use of nationally 370 
representative data of the U.S. population. We were able to adjust for major confounders such 371 
as education and PIR in our analysis. To our knowledge, this is the first study applying 372 
GWAS-like analytical approaches in studying determinants of obesity. Robustness of the 373 
statistical associations between investigated markers and obesity was ascertained through 374 
replication analysis and adjustment for presence of other metabolic factors. The systematic 375 
screening was able to eliminate factors with small effects which may be more prone to bias. 376 
Additionally, this method overcomes the limitation of selective reporting, which may be an 377 
issue with studies focusing on individual exposures. Nevertheless, it is important to address 378 
limitations of this study. NHANES III was set up as a cross-sectional study, thus our analysis 379 
was unable to identify any causality. Some nutrition and lifestyle factors were only measured 380 
in small numbers of the participants and this may have limited statistical power of the 381 
analysis. Many of investigated factors, such as smoking status and dietary assessment, were 382 
self-reported. For dietary assessment, only one 24-hour dietary recall was used. Such 383 
imprecision arising from subjective instruments and potential recall bias [64] may have 384 
resulted in the discrepancy between findings from dietary intake and serum levels of 385 
antioxidants. Therefore, it is necessary to confirm these results with objective measurements 386 
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such as digitalised instruments to monitor energy balance [65]. Nevertheless, these results 387 
may also indicate a role of physiological factors involved in oxidative stress response 388 
pathways, which may have greater influence than dietary intake of antioxidants in 389 
determining their serum levels. Definition of other metabolic disorders was limited by data 390 
availability in NHANES III. For instance, diabetes was based on fasting glucose and not all 391 
participants were fasting at time of measurements. Although we took into account potential 392 
confounders and inter-correlation between replicated factors, residual confounding may have 393 
occurred. It should also be noted that there were non-replicated factors in this study such as 394 
fat intake and serum cotinine that were individually correlated to abdominal obesity but did 395 
not display FDR<5% or significance in the replication set. Similarly, the association between 396 
aspartame intake and abdominal obesity may not have been gender-specific given a similar 397 
but weaker estimate in men after adjustment for multiple comparisons. These factors may still 398 
be associated, albeit weakly, with abdominal obesity. Furthermore, we were unable to 399 
exclude the potential role of other relevant factors apart from those assessed in NHANES III. 400 
Therefore, obtaining an equivalent definition of ‘genome-wide significance’ as one would be 401 
able to claim in a GWAS analysis may be impractical or otherwise requires more rigorous 402 
and thorough assessments of nutrition and lifestyle determinants. 403 
Conclusion 404 
Using a comprehensive screening, our study identified nutrition and lifestyle factors 405 
demonstrating robust associations with abdominal obesity. Future mechanistic investigations 406 
are necessary in order to draw conclusions which may lead to development of suitable 407 
behavioural intervention and public policies aimed to reduce the obesity pandemic. 408 
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